DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M. et al.
HERA study team 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial.
Lancet 2007;
369: 29-36
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.